REGN
Regeneron Pharmaceuticals Inc.StockHealthcare$609.94+$2.01 (+0.33%)as of Jun 18, 4:00 PM ET
Key stats
- Market cap
- 57.3B
- P/E (ttm)
- 13.0×
- Fwd P/E
- 11.3×
- P/S
- 3.8×
- P/B
- 1.8×
- EPS (ttm)
- $40.96
- EV/EBITDA
- 13.7×
- EV/Sales
- 3.8×
- P/FCF
- 13.9×
- FCF yield
- 7.18%
- Net margin
- 29.65%
- ROE
- 14.08%
- ROA
- 10.82%
- Debt / equity
- 0.06×
- Current ratio
- 3.57
- Beta
- 0.24
- Div yield
- 0.62%
- 52W high
- -25.72%
- Rel volume
- 2.20×
- 30D $ vol
- 753.5M
Performance
1D
+0.33%
1W
-0.25%
1M
-3.23%
3M
-17.29%
YTD
-21.43%
1Y
+19.86%
5Y
+16.06%
Financial statements
Open full REGN financials →Related Healthcare
1MRegeneron Pharmaceuticals Inc. (REGN) trades at $609.94 with a live price and an interactive chart covering 23+ years of daily price history, plus key valuation metrics. ChartRow also publishes REGN's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full REGN financial statements →